Hospira Symbiq Infusion Pumps Recalled for Backup Battery Failure
Hospira is recalling Symbiq Two Channel Infusers due to a backup battery failure caused by incorrect component installation on some power supply boards.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a medical device malfunction that could affect patient safety, fitting the 'High' severity criteria for risk-of-harm products.
Plain-English summary
Hospira Inc. is recalling 15,285 Symbiq Two Channel Infuser medical devices. These prescription infusion pumps are used to administer intravenous fluids. The recall covers units distributed nationwide in the United States and in Canada.
The recall is due to reports of Malfunction S205 Backup Battery Failure alarms. This issue is attributed to the incorrect installation of components on some Power Supply Controller (PSC) Boards distributed prior to September 2012. On affected pumps, the backup battery power discharges and cannot be recharged. This depletion triggers a visual and audible S205 warning alarm, which is intended to notify the user that the coin cell battery powering the backup buzzer may need to be charged or replaced.
Healthcare facilities should check their inventory for the specific serial numbers listed in the recall notice. Affected units should be removed from service and returned to Hospira for repair or replacement.
The recalled product
- Product
- Symbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids; Product List Number 16027
- Manufacturer
- Hospira Inc.
- Category
- Medical Device — Infusion Pump
- Affected units
- 15,285
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Hospira Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · device malfunction
See all →- HighPhilips Incisive CT Recalled for Potential Failure to Trigger Clinical Scan
FDA (Devices) · 2026-09-02
- HighBoston Scientific Recalls Suture Cinch Endoscopic Tissue Approximation Devices
FDA (Devices) · 2026-08-26
- HighBD Needle Kit for Powered Driver Recall Due to Removal Difficulty
FDA (Devices) · 2026-08-26
- SevereGEM Premier 5000 PAK Lysing Solution Concentration Recall
FDA (Devices) · 2026-08-12
- SevereStryker AHTO Tube Set Packaging Recalled for Handpiece Leaking
FDA (Devices) · 2026-08-12